Inventor · disambiguated record
Haiquan Fang
Also filed as: FANG HAIQUAN
16 granted patents·4 pending applications·210 citations·filing 2000–2024
92Inventor score
Files withBRISTOL MYERS SQUIBB CO9INST PHARMACEUTICAL DISCOVERY3JACOBIO PHARMACEUTICALS CO LTD3BRISTOL MYERS SQIBB COMPANY1INST FOR PHARM DISCOVERY INC1
Top patents by PatentIndex Score
20 records- 0193US6469006B1Antiviral indoleoxoacetyl piperazine derivativesBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Oct 22, 2002·96 cites·13 claims
- 0291US11466005B2Tricyclic compoundsJACOBIO PHARMACEUTICALS CO LTD·Filed 2021·Granted Oct 11, 2022·2 cites·8 claims
- 0391US7384930B2Constrained compounds as CGRP-receptor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jun 10, 2008·21 cites·13 claims
- 0490US7465825B2Phenyl substituted carboxylic acidsINST PHARMACEUTICAL DISCOVERY·Filed 2005·Granted Dec 16, 2008·18 cites·8 claims
- 0590US7384931B2Constrained compounds as CGRP-receptor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jun 10, 2008·10 cites·6 claims
- 0688US6573262B2Composition and antiviral activity of substituted indoleoxoacetic piperazine derivativesBRISTOL MYERS SQIBB COMPANY·Filed 2001·Granted Jun 3, 2003·44 cites·33 claims
- 0775US8278320B2Azabicyclo[2.2.1]heptane compounds as alpha-7 nicotinic acetylcholine receptor ligandsMCDONALD IVAR M·Filed 2010·Granted Oct 2, 2012·4 cites·14 claims
- 0874US9751879B2Tricyclic compounds as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Sep 5, 2017·1 cites·13 claims
- 0974US8481555B2Aza-bicyclic amine N-oxide compounds as alpha-7 nicotinic acetylcholine receptor ligand pro-drugsLENTZ KIMBERLEY A·Filed 2011·Granted Jul 9, 2013·6 cites·9 claims
- 1074US2025011327A1Tricyclic compoundsJACOBIO PHARMACEUTICALS CO LTD·Filed 2024·Application pending·0 cites
- 1171US7470680B2Constrained compounds as CGRP-receptor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Dec 30, 2008·1 cites·9 claims
- 1268US9458179B2Quinuclidine, 1-azabicyclo[2.2.1]heptane, 1-azabicyclo [3.2.1]octane, and 1-azabicyclo[3.2.2]nonane compounds as alpha-7 nicotinic acetylcholine receptor ligandsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Oct 4, 2016·1 cites·7 claims
- 1367US9688669B2Oxazolidinones as modulators of mGluR5BRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jun 27, 2017·1 cites·12 claims
- 1465US7329680B2Heterocycle substituted carboxylic acidsINST PHARMACEUTICAL DISCOVERY·Filed 2004·Granted Feb 12, 2008·2 cites·29 claims
- 1561US12103929B2Tricyclic compoundsJACOBIO PHARMACEUTICALS CO LTD·Filed 2020·Granted Oct 1, 2024·0 cites·20 claims
- 1661US7524878B2Phenyl substituted carboxylic acidsINST PHARMACEUTICALS DISCOVERY·Filed 2004·Granted Apr 28, 2009·3 cites·50 claims
- 1758US7544680B2Constrained compounds as CGRP-receptor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jun 9, 2009·0 cites·9 claims
- 1856US2008146574A1Heterocycle Substituted Carboxylic AcidsINST PHARMACEUTICAL DISCOVERY·Filed 2008·Application pending·0 cites
- 1946US2016318928A1Tricyclic compounds as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 2041US2006100251A1Substituted phenylalkanoic acidsINST FOR PHARM DISCOVERY INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Haiquan Fang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →